泰和科技(300801.SZ):“硫化鋰的合成技術研究”等硫化物項目處於小試階段
格隆匯11月11日丨泰和科技(300801.SZ)在投資者互動平台表示,“未來公司將圍繞鋰電池電解液添加劑、鋰電、鈉電正負極材料等新能源相關產品進行持續研發、項目建設和業務佈局,成長為新能源材料行業的新秀。”(摘自泰和科技2023年年度報吿)。另根據泰和科技2024年半年度報吿,“硫化鋰的合成技術研究”等硫化物項目處於小試階段,相關進展情況敬請關注後續披露的年度報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.